Navigation Links
Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
Date:6/17/2008

journal also covers management, education and novel therapies. Articles are rigorously peer- reviewed by a panel of international experts. http://www.journalofwoundcare.com.

Contact: Derma Sciences Inc Allen & Caron Inc

Edward J. Quilty Rudy Barrio (US Investors)

Chairman and CEO r.barrio@allencaron.com

equilty@dermasciences.com

(609) 514-4744 Brian Kennedy (media)

brian@allencaron.com

(212) 691-8087


'/>"/>
SOURCE Derma Sciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
2. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
3. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
4. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
5. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
6. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
7. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
10. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
11. Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Concord Medical Services ... leading specialty hospital management solution provider and operator of the ... China , today announced it will release its ... market closes on August 17, 2015. Management will ... day, at 8:00 a.m. EDT on August 18, 2015 (8:00 ...
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... and Companies" to their offering. ... its application in veterinary medicine and pharmaceuticals as ... animal genetics is important in the application of ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... 1 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... obesity, today announced that the U.S. Food and Drug ... Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its ... is based on a substantial body of evidence gathered ...
... , IRVINE, Calif. , June 1 Cardiogenesis ... present at the Noble Financial Sixth Annual Equity Conference - ONTRACK ... Hollywood, Florida .  Executive Chairman Paul J. McCormick will ... at 5:00 pm Eastern Time ( 2:00 pm ...
Cached Medicine Technology:Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity 2Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity 3Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010 2
(Date:8/5/2015)... ... August 05, 2015 , ... ... world’s thickest and strongest tent for those with height restrictions. Gorilla Grow Tent ... finest materials in the tent construction, attention to detail and overall superiority in ...
(Date:8/5/2015)... ... August 05, 2015 , ... "Art de Toilettes" , ... employees to suggest ideas to add some fun and visual interest to the ... idea to transform toilets into works of art. Renew Life makes natural digestive ...
(Date:8/5/2015)... ... August 05, 2015 , ... Six major Moodle service ... (Moodlerooms, NetSpot and Remote-Learner UK) - have formed the Partners of Open source ... improve and streamline the process for Moodle plugin development, one of the most ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... (“Frugal Financial”), a wholly-owned subsidiary. Frugal Financial is a registered investment advisor, serving ... complement and extend Employee Fiduciary’s core values and services , providing low-cost, ...
(Date:8/5/2015)... ... , ... Jvion’s CEO, Shantanu Nigam , was named Readers’ choice: 21 ... designation is given to those leaders who are enabling innovation within healthcare IT. Shantanu ... firm’s clinical predictive analytic solutions. , A spokesperson for Jvion said, “Since our inception, ...
Breaking Medicine News(10 mins):Health News:Best Grow Tent and Indoor Greenhouse Brand Gorilla Grow Tent Launches New Shorty Line 2Health News:Fantastic Team Spirit and Creativity Prevailed at Renew Life “Art de Toilettes” 2Health News:Moodle Service Providers to Simplify Moodle Plugin Development 2Health News:Moodle Service Providers to Simplify Moodle Plugin Development 3Health News:Moodle Service Providers to Simplify Moodle Plugin Development 4Health News:Employee Fiduciary Announces Subsidiary 2Health News:Jvion’s Shantanu Nigam Named One of the 21 Health IT Leaders to Know 2
... Web Site Strategy and Design, NEW YORK, ... been selected to develop a new web site ... of Public Health, one of the world,s,leading research, ... public health issues., "The Mailman website provides ...
... the,release of a new slimmer and more streamlined SenseWear(R) ... is 40% smaller than the previous model and weighs ... ergonomic,design intended to provide improved comfort and can be ... little device that could have a huge impact on,behavior ...
... Detroit bring up the rear, survey says , , MONDAY, May ... hearts in tip-top shape face the fewest challenges in Minneapolis, ... the list of the 10 most heart-healthy U.S. metropolitan areas ... But the list, released Monday by the American Heart Association, ...
... unnecessary surgeries , , MONDAY, May 19 (HealthDay News) ... lectin molecule called galectin-3 could help improve identification of ... surgeries, according to an Italian study. , The ... is to examine cells extracted by fine-needle aspiration. About ...
... survey says , , MONDAY, May 19 (HealthDay News) -- Women ... the fewest challenges in Minneapolis, Washington, D.C., and San Francisco. ... most heart-healthy U.S. metropolitan areas for women, a list that,s ... by the American Heart Association, also found the 10 metropolitan ...
... Disease Awareness Levels, However, ... More Doctor Visits Are Still Needed -, ... three,years, Hispanic-Americans have become increasingly aware of a potentially,serious ... Reflux Disease. Approximately 6.1 million Hispanics in the United,States ...
Cached Medicine News:Health News:Format-Studio Selected by Columbia University Mailman School of Public Health 2Health News:BodyMedia Releases New & Improved SenseWear(R) WMS Armband 2Health News:Minneapolis Tops List of Heart-Friendly Cities for Women 2Health News:Minneapolis Tops List of Heart-Friendly Cities for Women 3Health News:Protein Helps ID Thyroid Cancer Nodules 2Health News:Minneapolis Tops List of Heart-Healthy Cities for Women 2Health News:Minneapolis Tops List of Heart-Healthy Cities for Women 3Health News:New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD 2Health News:New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD 3Health News:New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD 4Health News:New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD 5
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
Zone Quick is a simple and accurate system that measures tear volume in just 15 seconds per eye. Each box has an easy to read diagnostic indicator rule....
... has received the FDA approval to market ... in enucleation procedures in the United States. ... strong, non-brittle biomaterial alumina (AL2, O3), and ... 500m in size. The vicryl (polyglactin 910) ...
...
Medicine Products: